Document
IPR2021-00406, No. 1107-199 Exhibit - Reply Declaration of Igor Gonda, PhD (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1107-199 Exhibit - Reply Declaration of Igor Gonda, PhD (P.T.A.B. Feb. 10, 2022)
+ More Snippets
Document
IPR2021-00406, No. 1104-196 Exhibit - Sulica, R and Poon, M, ���Medical therapeutics for pulmonary arterial hypertension from basic science and clinical trial design to evidence based medicine...
Cite Document
IPR2021-00406, No. 1104-196 Exhibit - Sulica, R and Poon, M, ���Medical therapeutics for pulmonary arterial hypertension from basic science and clinical trial design to evidence based medicine,��� Exp
+ More Snippets
Document
IPR2021-00406, No. 1100-193 Exhibit - Ventavis EU Summary of Product Characteristics (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1100-193 Exhibit - Ventavis EU Summary of Product Characteristics (P.T.A.B. Feb. 10, 2022)
+ More Snippets
Document
IPR2021-00406, No. 1095-188 Exhibit - Voswinckel JAHA, Stanford (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1095-188 Exhibit - Voswinckel JAHA, Stanford (P.T.A.B. Feb. 10, 2022)
+ More Snippets
Document
IPR2021-00406, No. 3003-241 Exhibit - Ex 3003 (P.T.A.B. Aug. 22, 2022)
Cite Document
IPR2021-00406, No. 3003-241 Exhibit - Ex 3003 (P.T.A.B. Aug. 22, 2022)
+ More Snippets
Document
IPR2021-00406, No. 1009-9 Exhibit - Voswinckel, et al, ¿¿¿Clinical Observations¿¿¿ on ¿¿¿Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension,¿¿¿ ¿¿¿Letters¿¿¿ Section of the...
Cite Document
IPR2021-00406, No. 1009-9 Exhibit - Voswinckel, et al, ¿¿¿Clinical Observations¿¿¿ on ¿¿¿Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension,¿¿¿ ¿¿¿Letters¿¿¿ Section of the
+ More Snippets
Document
IPR2021-00406, No. 1070-67 Exhibit - Beasley, R, et al, ¿¿¿Preservatives in Nebulizer Solutions Risks without Benefit,¿¿¿ Pharmacotherapy, 181130 39 1998 (P.T.A.B. Jan. 7, 2021)
Cite Document
IPR2021-00406, No. 1070-67 Exhibit - Beasley, R, et al, ¿¿¿Preservatives in Nebulizer Solutions Risks without Benefit,¿¿¿ Pharmacotherapy, 181130 39 1998 (P.T.A.B. Jan. 7, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1057-55 Exhibit - October 24, 2005 Press Release, ¿¿¿Aradigm Corporation And United Therapeutics Corporation Sign Development and Commercialization Agreement Targ...
Cite Document
IPR2021-00406, No. 1057-55 Exhibit - October 24, 2005 Press Release, ¿¿¿Aradigm Corporation And United Therapeutics Corporation Sign Development and Commercialization Agreement Targeting Pulmonary Hyp
+ More Snippets
Document
IPR2021-00406, No. 1065-62 Exhibit - Olschewski, H, et al, ¿¿¿Inhaled Iloprost for Several Pulmonary Hypertension,¿¿¿ N Engl J Med, 3475322 29 2002 (P.T.A.B. Jan. 7, 2021)
Cite Document
IPR2021-00406, No. 1065-62 Exhibit - Olschewski, H, et al, ¿¿¿Inhaled Iloprost for Several Pulmonary Hypertension,¿¿¿ N Engl J Med, 3475322 29 2002 (P.T.A.B. Jan. 7, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1018-18 Exhibit - Remodulin¿¿ 2004 Label (P.T.A.B. Jan. 7, 2021)
Cite Document
IPR2021-00406, No. 1018-18 Exhibit - Remodulin¿¿ 2004 Label (P.T.A.B. Jan. 7, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1076-72 Exhibit - October 23, 2017 Press Release, ¿¿¿United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso¿¿ Inhalation System¿¿¿ (P...
Cite Document
IPR2021-00406, No. 1076-72 Exhibit - October 23, 2017 Press Release, ¿¿¿United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso¿¿ Inhalation System¿¿¿ (P.T.A.B. Jan. 7,
+ More Snippets
Document
IPR2021-00406, No. 1047-45 Exhibit - Hoeper, MM, et al, ¿¿¿Long Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue,¿¿¿ N Engl J Med, 342186...
Cite Document
IPR2021-00406, No. 1047-45 Exhibit - Hoeper, MM, et al, ¿¿¿Long Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue,¿¿¿ N Engl J Med, 3421866 70 (P.T.A.
+ More Snippets
Document
IPR2021-00406, No. 1023-23 Exhibit - Olschewski, H, et al, ¿¿¿Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis,¿¿¿ American Journal of Respiratory...
Cite Document
IPR2021-00406, No. 1023-23 Exhibit - Olschewski, H, et al, ¿¿¿Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis,¿¿¿ American Journal of Respiratory Critical
+ More Snippets
Document
IPR2021-00406, No. 1042-41 Exhibit - January 27, 2020 Press Release, ¿¿¿Liquidia Submits New Drug Application for LIQ861 Treprostinil Inhalation Powder to US Food And Drug Administration f...
Cite Document
IPR2021-00406, No. 1042-41 Exhibit - January 27, 2020 Press Release, ¿¿¿Liquidia Submits New Drug Application for LIQ861 Treprostinil Inhalation Powder to US Food And Drug Administration for the Treat
+ More Snippets
Document
IPR2021-00406, No. 1019-19 Exhibit - Stein, SW, et al, ¿¿¿The History of Therapeutic Aerosols A Chronological Review,¿¿¿ Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30120 41 201...
Cite Document
IPR2021-00406, No. 1019-19 Exhibit - Stein, SW, et al, ¿¿¿The History of Therapeutic Aerosols A Chronological Review,¿¿¿ Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30120 41 2017 (P.T.A.B
+ More Snippets